Twist Bioscience Corporation
TWSTNASDAQHealthcareDiagnostics & Research
As of Oct 15, 2026 close
- Market cap
- $9.02B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $23.30$219.71
- Volume (live)
- -
- Avg. volume (3M)
- 2.70M
Twist Bioscience (TWST) Stock Price & Financial Analysis
Twist Bioscience Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $130.68 - $148.32 |
|---|---|
| 52-Week High | $219.71 |
| 52-Week Low | $23.30 |
| Open | $138.09 |
| Volume (last close) | 3.54M |
| Average Volume (3M) | 2.70M |
| Revenue (TTM) | 431.80M |
|---|---|
| Net Income (TTM) | -136.72M |
| Free Cash Flow (TTM) | -93.12M |
| EPS (TTM) | −$2.23 |
| Profit Margin | -31.66% |
| Operating Margin | -33.62% |
| Return on Equity (ROE) | -30.67% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 9.02B |
|---|---|
| Shares Outstanding | 62.40M |
| Price to Sales (P/S) | 20.88 |
| Price to Book (P/B) | 20.23 |
| EV/EBITDA | -78.07 |
| 50-Day MA | $146.85 |
|---|---|
| 200-Day MA | $82.20 |
| 1-Year Change | +369.89% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Twist Bioscience at a Glance
As of the Oct 15, 2026 close, Twist Bioscience (TWST) has a market capitalization of $9.02B. The stock trades at 20.9× sales. Over the trailing twelve months it lost $136.72M on revenue of $431.80M and burned $93.12M of free cash flow. Revenue grew 19.2% year over year.
As of its latest reported balance sheet, it holds $117.44M in cash and securities against $93.59M of debt, a net cash position of $23.85M.
Twist Bioscience does not currently pay a dividend.
The share price is up 369.9% over the past year. At $144.49 (the Oct 15, 2026 close) it sits within its 52-week range of $23.30 to $219.71, above its 200-day moving average of $82.20.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $142.10, 1.7% below the Oct 15, 2026 close.
Frequently Asked Questions About Twist Bioscience
What is the current stock price for TWST?
As of the Oct 15, 2026 close, TWST stock trades at $144.49. The 52-week range is $23.30–$219.71, with a day range of $130.68–$148.32.
What is the P/E ratio for TWST?
The P/E ratio (Price-to-Earnings) for TWST is shown in the Key Statistics section. This valuation metric helps compare Twist Bioscience Corporation to industry peers.
Does TWST pay dividends?
Twist Bioscience does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TWST?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for TWST is Buy. The average 12-month price target is $142.10, a 1.7% downside from the Oct 15, 2026 close of $144.49.
What is the market cap of TWST?
As of the Oct 15, 2026 close, Twist Bioscience's market capitalization is $9.02B, classifying it as a mid-cap company. Twist Bioscience operates in the Healthcare sector within the Diagnostics & Research industry.